Machine Learning for Early Prediction of Major Adverse Cardiovascular Events After First Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: Retrospective Cohort Study

Machine Learning for Early Prediction of Major Adverse Cardiovascular Events After First Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: Retrospective Cohort Study

BackgroundThe incidence of major adverse cardiovascular events (MACEs) remains high in patients with acute myocardial infarction (AMI) who undergo percutaneous coronary intervention (PCI), and early prediction models to guide their clinical management are lacking....

Full description

Bibliographic Details
Main Authors:	Pin Zhang, Lei Wu, Ting-Ting Zou, ZiXuan Zou, JiaXin Tu, Ren Gong, Jie Kuang
Format:	Article
Language:	English
Published:	JMIR Publications 2024-01-01
Series:	JMIR Formative Research
Online Access:	https://formative.jmir.org/2024/1/e48487

Similar Items

Using the Super Learner algorithm to predict risk of major adverse cardiovascular events after percutaneous coronary intervention in patients with myocardial infarction
by: Xiang Zhu, et al.
Published: (2024-03-01)

Predictive Model for Long-term Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
by: Qin LI, Xin TAN, Wenxi JIANG, Meng YUAN, Hui NI, Yuan WANG, Jie DU
Published: (2022-08-01)

RISK FACTORS FOR SHORT-TERM MAJOR ADVERSE CARDIOVASCULAR EVENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH TYPE 2 DIABETES MELLITUS
by: LOU Dongliang, BAI Yuxiao, JIANG Weifeng, ZHANG Haohao, SUN Jihong
Published: (2023-12-01)

Impact of Three-Dimensional Strain on Major Adverse Cardiovascular Events after Acute Myocardial Infarction Managed by Primary Percutaneous Coronary Intervention—A Pilot Study
by: Raluca Tomoaia, et al.
Published: (2021-09-01)

Predictive value of residual inflammation risk-based nomogram model for major adverse cardiovascular events in acute myocardial infarction patients after percutaneous coronary intervention
by: CAO Jiaoyu, et al.
Published: (2021-09-01)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Zhihao Chen, et al.
Published: (2018-11-01)

Risk Factors and Predictive Value of Risk Scoring Systems for Long-term Major Adverse Cardiovascular Events in Patients with ST-segment Elevation Myocardial Infarction Following Percutaneous Coronary Intervention
by: ZHANG Guoli, ZHAO Rongrong, PENG Guotian, SUN Ruiyi, QIAO Pengyu, YAN Fanghong, HAN Lin
Published: (2024-05-01)

Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
by: Xiaoxiao Zhao, et al.
Published: (2020-11-01)

Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
by: Caoyang Fang, et al.
Published: (2022-12-01)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
by: Anping Cai, et al.
Published: (2019-11-01)

Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
by: Wenqi Deng, et al.
Published: (2024-01-01)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
by: Qiaoying Chai, et al.
Published: (2023-09-01)

Analysis between high risk of myocardial infarction with non‐obstructive coronary artery disease in single center and occurrence of major adverse cardiovascular events
by: Meihong Kong, et al.
Published: (2022-11-01)

Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention
by: Zhao X, et al.
Published: (2022-07-01)

Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary intervention
by: Chung-Wah Siu, et al.
Published: (2022-01-01)

Relationship between Prognostic Nutritional Index and Major In-hospital Adverse Cardiovascular Events after Percutaneous Coronary Intervention in Patients with Acute ST-elevation Myocardial Infarction Complicated by Type 2 Diabetes Mellitus
by: ZHAO Banghao, YUAN Teng, ZHAO Ling, AMANGULI Ruze, NILUPAER Xiefukaiti, MA Yitong, YANG Yining, GAO Xiaoming
Published: (2024-05-01)

Correlations of visfatin with severity of acute myocardial infarction, cardiovascular risk factors and atrial fibrillation after percutaneous coronary intervention
by: Zhang Huihui, et al.
Published: (2023-01-01)

The prediction value of platelet-derived growth factor for major adverse cardiovascular events in patients with acute non-ST-segment elevation myocardial infarction
by: Yan Liang, et al.
Published: (2023-12-01)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
by: Hossein Farshidi, et al.
Published: (2018-02-01)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction.
by: Junyu Pei, et al.
Published: (2020-01-01)

Association between the level of high-sensitivity troponin I (Hs-Trop I) and major adverse cardiovascular events in patients with acute myocardial infarction of segment elevation (STEMI) with primary percutaneous coronary intervention (PCI)
by: Daniel Daniel, et al.
Published: (2022-05-01)

Nutritional Status and Recurrent Major Cardiovascular Events Following Acute Myocardial Infarction—A Follow-Up Study in a Primary Percutaneous Coronary Intervention Center
by: Maria Czinege, et al.
Published: (2024-04-01)

Sex differences following percutaneous coronary intervention or coronary artery bypass surgery for acute myocardial infarction
by: Donna Shu-Han Lin, et al.
Published: (2022-04-01)

Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
by: Yao Yao, et al.
Published: (2024-01-01)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
by: Shuting Kong, et al.
Published: (2021-05-01)

Periprocedural Myocardial Infarction following Elective Percutaneous Coronary Interventions
by: Antonio Landi, et al.
Published: (2022-09-01)

Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Morteza Safi, et al.
Published: (2009-01-01)

Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Seyed Ahmad Hassantash, et al.
Published: (2009-03-01)

Illness perception and cardiovascular risk factors in patients with myocardial infarction undergoing percutaneous coronary intervention in Iran
by: Aysan Thagizadeh, et al.
Published: (2022-06-01)

Longitudinal change of serum exosomal miR-186-5p estimates major adverse cardiac events in acute myocardial infarction patients receiving percutaneous coronary intervention
by: Lingyun Ren, et al.
Published: (2024-04-01)

Cystatin C as a Predictor of Major Adverse Cardiovascular Event in Patients with Acute Myocardial Infarction Without Cardiogenic Shock and Renal Impairment After Coronary Intervention
by: Wasyanto T, et al.
Published: (2023-06-01)

Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention
by: Morteza Chehrevar, et al.
Published: (2022-11-01)

Intelligent prediction of major adverse cardiovascular events (MACCE) following percutaneous coronary intervention using ANFIS-PSO model
by: Sahar Dehdar Karsidani, et al.
Published: (2022-08-01)

The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention
by: Anjum Naim, et al.
Published: (2022-01-01)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
by: S. Ramesh, et al.
Published: (2020-11-01)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
by: Lawrence Ang, et al.
Published: (2017-11-01)

Prediction models for major adverse cardiovascular events following ST-segment elevation myocardial infarction and subgroup-specific performance
by: Weiyao Chen, et al.
Published: (2023-04-01)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
by: Pu Shang, et al.
Published: (2019-05-01)

High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients
by: Sumarjaya IDGD, et al.
Published: (2020-04-01)